Three Blood Biomarkers Predict Higher Risk of Heart Attack, Stroke in Women

Translate to Spanish or other 102 languages!

Three blood biomarkers could help predict heart attack and stroke risk in women. Image for illustration purposes
Three blood biomarkers could help predict heart attack and stroke risk in women. Image for illustration purposes
- Advertisement -
  • Cardiovascular disease is the leading cause of death in women globally. 
  • There have historically been disparities in diagnosing cardiovascular disease in women as they may have no or different symptoms than men. 
  • Researchers from Brigham and Women’s Hospital found measuring three different biological blood markers can better predict a woman’s risk of having a major cardiovascular event over the next 30 years compared to measuring only one biomarker.

Cardiovascular disease is the leading cause of death in women around the globe, while stroke is the third most commonTrusted Source.

Follow the link to Medical News Today to read the full story:

https://www.medicalnewstoday.com/articles/3-blood-biomarkers-predict-higher-risk-of-heart-attack-stroke-in-women?slot_pos=article_2&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2024-09-11&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

DHR Health Brownsville’s 2nd Annual Fall Fest and Health Fair, Oct. 24th

DHR Health Brownsville is bringing families together for a day of wellness and fun at its 2nd Annual Fall Fest and Health Fair. The event will be held from 8 a.m. to noon on October 24, 2026, at the DHR Health Brownsville Hospital, at 4750 North Expressway 77, in north Brownsville. The event is free and open to the public.

The Impact of Physical Activity on Parkinson’s Decline

For 68-year-old Robert Kennedy, a retired Florida Power and Light foreman, the secret to managing his Parkinson symptoms is movement.

FDA Approves First-of-Its-Kind Chronic Hepatitis B Treatment 

The U.S. Food and Drug Administration approved Hibsago (bepirovirsen) injection, in combination with existing antiviral therapy, to treat chronic hepatitis B virus (HBV) infection in certain adults without cirrhosis.

Why Strength Training Is Your Best Defense Against Osteoporosis

Reports show women are at higher risk for developing the bone weakening condition as they get older.
- Advertisement -